The Immune Inductive Role of Hepatic Arterial Infusion Chemotherapy Prior to Atezolizumab Plus Bevacizumab Combination Therapy in Hepatocellular Carcinoma

• Hiroyuki Suzuki,
• Miwa Sakai,
• Hideki Iwamoto,
• Shigeo Shimose,
• Takashi Niizeki,
• Masahito Nakano,
• Tomotake Shirono,
• Yu Noda,
• Etsuko Moriyama,
• Ryoko Kuromatsu,
• Hironori Koga,
• Takumi Kawaguchi

Affiliations

Hiroyuki Suzuki

Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan; Liver Cancer Research Division, Research Center for Innovative Cancer Therapy, Kurume University, Kurume, Japan

Miwa Sakai

Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan

Hideki Iwamoto

Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan; Liver Cancer Research Division, Research Center for Innovative Cancer Therapy, Kurume University, Kurume, Japan; Iwamoto Internal Medicine Clinic, Kitakyushu, Japan; Correspondence: Address correspondence to: Hideki Iwamoto, MD, PhD, Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume 830-0011, Japan.

Shigeo Shimose

Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan

Takashi Niizeki

Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan

Masahito Nakano

Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan

Tomotake Shirono

Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan

Yu Noda

Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan

Etsuko Moriyama

Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan

Ryoko Kuromatsu

Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan; Liver Cancer Research Division, Research Center for Innovative Cancer Therapy, Kurume University, Kurume, Japan

Hironori Koga

Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan; Liver Cancer Research Division, Research Center for Innovative Cancer Therapy, Kurume University, Kurume, Japan

Takumi Kawaguchi

Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan